共 50 条
Current insights and future directions of LncRNA Morrbid in disease pathogenesis
被引:0
|作者:
Yang, Haiqiong
[1
,2
,3
]
Gao, Jiali
[4
,5
]
Zheng, Zaiyong
[1
,2
,3
]
Yu, Yang
[1
,2
,3
]
Zhang, Chunxiang
[1
,2
,3
]
机构:
[1] Southwest Med Univ, Affiliated Hosp, Dept Cardiol, Luzhou, Peoples R China
[2] Southwest Med Univ, Inst Cardiovasc Res, Key Lab Med Electrophysiol, Minist Educ, Luzhou, Peoples R China
[3] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent Cardiovasc Dis, Med Electrophysiol Key Lab Sichuan Prov, Luzhou, Peoples R China
[4] Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China
[5] Luzhou Peoples Hosp, Dept Pharm, Luzhou, Peoples R China
来源:
基金:
中国国家自然科学基金;
关键词:
Long non-coding RNA;
LncRNA Morrbid;
MIR4435-2HG;
Tumor;
Cardiovascular disease;
EPITHELIAL-MESENCHYMAL TRANSITION;
CANCER;
MIR4435-2HG;
PROGRESSION;
INHIBITION;
MICROENVIRONMENT;
IDENTIFICATION;
PROLIFERATION;
METASTASIS;
MIGRATION;
D O I:
10.1016/j.heliyon.2024.e36681
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Non-coding RNAs have emerged as important regulators of gene expression and contributors to many diseases. LncRNA Morrbid, a long non-coding RNA, has been widely studied in recent years. Current literature reports that lncRNA Morrbid is involved in various diseases such as tumors, cardiovascular diseases, inflammatory diseases and metabolic disorder. However, controversial conclusions exist in current studies. As a potential therapeutic target, it is necessary to comprehensively review the current evidence. In this work, we carefully review the literature on Morrbid and discuss each of the hot topics related to lncRNA Morrbid.
引用
收藏
页数:11
相关论文